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Objective: To analyse the clinical results and long-term patency rates of 108 patients with subclavian carotid transposition 
(SCT) and compare the outcomes toother clinical series using the same technique, aswell as to those reported for other 
surgical procedures and PTA in the treatment ofproximal subclavian artery disease. 
Methods: The hospital records of 108 patients with carotid subclavian transposition were retrospectively reviewed for 
preoperative symptoms, Doppler examination, arteriography, blood pressure differentials and postoperative complications. 
Long-term patency and symptoms were determined during a follow-up examination i cluding a history, physical 
examination, blood pressure differentials, Doppler examinations and arteriography in selected cases. 
Results: The indication for SCT were subclavian steal (78 %), upper extremity ischaemia (59 %), rest pain or acral 
necrosis (5 %), vertigo (6 %). There was no mortality, blood pressure differentials were equalised in all patients without 
any early reocclusions. The complication rate was 15 % with a permanent morbidity of 3 %. Eighty-four patients (77 %) 
could be re-examined during follow-up. For them the overall patency after a mean observation period of 70 months (1-144 
months) was 100 %. 
Conclusions: Subclavian carotid transposition is an excellent method for the treatment ofproximal subclavian occlusive 
disease because of its exceptional long-term patency and low morbidity. 
Introduction 
Subclavian-carotid transposition (SCT) for the treat- 
ment of subclavian artery occlusive disease was first 
described by Parrot in 1964.1 In this procedure the 
subclavian artery is transected just distal to the 
stenotic or occluding lesion and implanted end-to-side 
into the ipsilateral common carotid artery. In recent 
years this operation has gained much popularity, 
because of several advantages over transthoracic in 
situ repair or extra-anatomic bypass procedures. The 
technique is relatively simple and allows the simulta- 
neous repair of ipsilateral carotid- and vertebral artery 
disease via a common cervical incision. A single 
autogenous anastomosis imitating the natural anat- 
omy produces a favourable haemodynamic situation 
with physiologic orthograde bloodflow in the sub- 
clavian artery. Embolic sources are simultaneously 
excluded. Due to the extrathoracic approach the 
operative risk is low, and due to the absence of 
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prosthetic material, graft related complications are 
avoided. 
Subclavian arterial occlusive disease may present as 
a multitude of cerebrovascular insufficiency symp- 
toms (subclavian steal) or may be asymptomatic. In
addition, stenosis of the subclavian artery can produce 
embolic phenomenon to the hand or arm ischaemia. 
Surgical indications are established for the subclavian 
steal syndrome 2'3 and disabling arm ischaemia or 
both. Extrathoracic revascularisation has become the 
principle form of surgical treatment of symptomatic 
subclavian disease. Transthoracic repair 4 is quite 
uncommon toda)~ even if excellent results have been 
obtained in the past. s Along with SCT, extra-anatomic 
axillo-axillar~ subclavio-subclavian d carotid-sub- 
clavian artery bypass procedures have been 
employed. Inspite of some theoretical advantages, a 
lack of significant comparative clinical data has 
prevented SCT from gaining widespread acceptance 
in the past, while today percutaneous transluminal 
angioplasty (PTA) appears to be an increasingly 
attractive alternative to surgery. We compared our 
clinical short- and long-term results with 108 SCTs 
with the results from several published series employ- 
ing SCT, different bypass procedures and PTA in order 
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to estimate the value of SCT in the treatment of 
proximal subclavian artery disease. 
Patients and Methods 
One hundred and eight patients underwent SCT at 
our institution from 1979 to June 1995. The indication 
for surgery were symptoms referable to a stenosis or 
occlusion of the proximal subclavian artery. Patients 
who underwent transthoracic repair of complex 
lesions and those who underwent other extrathoracic 
types of repair were excluded from the study unless 
SCT was carried out simultaneously. Patency rates 
refer to the patency of the transposition i  all cases. 
The hospital records of all patients were reviewed 
retrospectively to determine the presenting clinical 
manifestations, the extent and location of the lesion on 
aortic arch angiography, the results of the CW- 
Doppler ultrasonographN details of the operation, and 
immediate postoperative course. The study group 
consisted of 53 women and 55 men, with a median age 
of 59 years. The side affected was the left subclavian 
artery in 94 cases and the right in 14. 
Preoperative f atures 
All patients were symptomatic at the time of opera- 
tion. Seventy-seven percent (n = 84) suffered from a 
Subclavian-Steal-Syndrome, experiencing verteboba- 
silar symptoms uch as dizziness, drop attacks, or 
vertigo during ipsilateral arm exercise. Stress induced 
upper extremity ischaemia occured in 59 % (n = 64). 
Rest-pain occured in three (3 %) and acral necrosis in 
two (2 %) patients. Both SSS and Stress induced upper 
extremity ischaemia was present in 37 % (n = 40). Non- 
specific vertigo was reported in six (5.5 %) patients. 
Along with radiological and sonographic proof of 
proximal subclavian stenosis or occlusion and haemo- 
dynamic steal the following blood pressure differ- 
ences were recorded. In 18 (17 %) patients, the brachial 
blood pressure on the affected side was undetectable. 
78 (72 %) had a blood pressure difference of more than 
30 mm Hg, and 12 (11%) had a difference between 20 
and 30 mm Hg, when compared to the healthy 
contralateral side. Total occlusion was found on arch 
angiography in 65 and subtotal stenosis in 43 cases. 
Associated risk factors for the development of arterio- 
sclerosis were recorded (Table 1). The majority of 
patients presented with 1 or 2 risk factors (Table 2). 
Seventy-two patients (66.6 %) had associated isease, 
Table 1. Associated risk factors (n=108). 
Risk factor n (%) 
Smoking 60 (56) 
Hypertension 71 (66) 
Diabetes mellitus 7 (7) 
Hyperlipidaemia 30 (23) 
primarily cardiovascular, cerebrovascular or other 
peripheral arterial occlusive disease. 
Surgical technique 
The approach is along the medial margin of the 
sternocleidomastoid muscle. The incision starts just 
below the level of the hyoid bone and is extended 
distally medially and below the sternoclavicular joint. 
In the case of associated internal carotid artery disease 
the incision is extended towards the mastoid bone and 
desobliteration f the carotid artery is carried out prior 
to SCT. Medial to the internal jugular vein the 
common carotid artery is used as a guideline as 
dissection moves towards the mediastinum well 
below the level of the clavicle. Close to the aortic arch 
the subclavian artery, lying dorsolateral is exposed by 
blunt dissection. To avoid lymphatic damage, the area 
of dissection should be kept caudal to the thoracic 
duct. The subclavian artery carefully is suture-ligated 
and transected close to the aortic arch or brachioce- 
phalic trunk respectivel~ in order to obtain a suffi- 
ciently long peripheral stump for a tension-free nd- 
to-side anastomosis to the common carotid artery. If 
necessar~ the peripheral subclavian artery stump can 
be endarterectomised, including the orifice of the 
vertebral artery. The final step is the oblique and 
haemodynamically favourable implantation of the 
subclavian artery into the dorsolateral side of the 
common carotid artery. This may be achieved by 
twisting the common carotid artery 45 ° forward 
during suturing of the anastomosis. 
Desobliteration and patch plasty of the ipsilateral 
internal carotid artery was carried out prior to SCT in 
15 cases (14 %), because of associated severe stenosis. 
Table 2. Number of associated risk factors per patient (n=108). 
Number of risk factors n (%) 
0 7 (7) 
1 45 (42) 
2 45 (42) 
3 9 (8) 
4 2 (2) 
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In three patients combined procedures were per- 
formed, due to additional diseases like acral necrosis, 
hyperkinetic heart syndrome and contralateral sten- 
osis of the inominate artery. There was one each of 
carotid sinus denervatin, thoracic sympatectomy and 
aortotruncal bypass. The mean time of surgery for 
SCT was 89 +/ -  26 min. SCT and simultaneous 
internal carotid desobliteration required 146 +/ -  36 
min. The common carotid artery cross-clamping time 
was 15 + 6 min. 
Follow-up 
Although some long-term results were obtained from 
records of follow-up visits and from examination of 
patients in the clinic, all patients were asked to attend 
for follow-up examination. Follow-up ranged from 1 
to 144 months (mean 70 months). Three Patients (3 %) 
were lost to follow-up. Four patients (4 %) suffering 
from debilitating cardio- or cerebrovascular disease 
could not be transported to our center for follow-up 
examination. Seventeen patients (16 %) had died from 
various causes. Eighty-four could be re-examined, 
accounting for 92 % of the surviving patients (Table 3). 
Patency of the reconstruction was assessed by a 
history of symptoms, physical examination, blood 
pressure measurements, CW-Doppler ultrasonogra- 
phy and angiography in selected cases. 
Results 
No mortality associated with 108 SCTs was observed 
(Table 4). In all patients the brachial blood pressure 
was equalised to within 20 mm Hg without any 
perioperative reocclusion. With the exception of two 
TIAs, one occurring in the vertebrobasilar ea, no 
central neurologic deficits were encountered. Four 
operative revisions were required for postoperative 
Table 3. Complications. 
Complication n (%) 
TIA 
Homer syndrome 
Recurrent erve palsy 
Lymphatic fistula (surgical revision) 
Postoperative haemorrhage (surgical revision) 







Total 16 (15) 
*Permanent morbidity 3 (3) 
Table 4. Late results. 
Follow-up examination 84 (78%) 
Dead 17 (16%) 
Unable to attend follow-up 4 (4%) 
Not contacted 3 (3%) 
Re-examined patients: 
Patency 84 (100%) 
Steal syndrome orarm ischaemia 0 
Restenosis CW-Doppler xamination 11 (13%) 
BP difference ~ 20 mm HG 2 (2%) 
haemorrhage and three for lymphatic fistulas. Four 
patients suffered from recurrent nerve paralysis 
which, however, was reversible in all cases. Permanent 
irreversible Horner's syndrome due to cervical sym- 
pathetic injury was encountered twice. One patient 
with staged contralateral carotid desobliteration 1 
week prior to SCT developed respiratory insufficiency 
due to pneumonia, complicated by a heart attack 
(Table 4). The overall perioperative complication rate 
was 15 % and the permanent morbidity 3 %. 
In all 84 patients re-examined, the subclavian artery 
was patent after a mean follow-up of 70 months 
(Range 1-144 months) (Table 3). The actuarial patency 
rate according to the Kaplan-Meier-Analysis was 100 
% (Fig. 1). None of the patients was symptomatic for a 
SSS. CW-Doppler sonography uncovered asympto- 
matic restenosis in 11 patients (13 %). Due to a lack of 
Doppler sonographic ontrol in the immediate post- 
operative period it remains unclear whether these 
stenoses were caused by arteriosclerosis or technical 
inadequacy of the reconstruction. A blood pressure 
difference of more than 20 mm Hg, however, was 
detected in only two (3 %) asymptomatic patients. 
Subjective results were obtained by questioning the 
patients. 77 (2 %) said they were asymptomatic six (7 
%) found symptoms had improved and one patient 
felt that surgery had not relieved his symptoms. 79 
patients (94 %) were glad that surgery had been 
carried out and would in the presence of identical 
problems again decide to have an operation carried 
out. 
The actuarial ong term survival was determined 
with a Kaplan-Meier Analysis (Fig. 1). In most cases 
death was caused by stroke or myocardial infarction 
(Table 5). 
Discussion 
SCT has several advantages over other extra-anatomic 
reconstructions for subclavian revascularisation. No 
prosthetic material is needed and problems with graft 
infection are avoided. With a single autogenous end- 
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Fig. 1. Kaplan-Meier-Analysis calculating actuarial rates for patency and survival in 108 patients with subclavian carotid transposition. 
to-side anastomosis normal blood-flow into the verte- 
bral and subclavian arteries can be restored, initiating 
the natural anatomy. PseudointimaI hyperplasia 
resulting from compliance mismatch is not a problem 
because autogenous material with identical physi- 
oelastic properties i used. This physical advantage is 
mirrored in the clinical results of our patients with an 
actuarial patency rate of 100 % (Fig. 1). When looking 
at our results combined with those presented in the 
literature there are only four reported reocclusions in 
more than 500 cases (Table 6). The procedure offers 
several other major advantages: the embolic source is 
simultaneously excluded, lesions extending into the 
vertebral artery can be removed by eversion endarter- 
ectomy and a desobliteration f the internal carotid 
artery can be carried out by simply extending the 
incision towards the mastoid bone. Carotid endarter- 
ectomy is always carried out prior to SCT under shunt 
protection i  order to avoid ipsilateral cerebral ischae- 
mia due to hypoperfusion during common carotid 
cross-clamping. This combined procedure was carried 
out in 15 of our patients without CNS complications. 
Strokes during common carotid cross-clamping have 
not been observed in our or any other eported series. 6
External carotid collateralisation a d the brief occlu- 
sion time, which amounted to about 15 min in our 
Table  5. Causes  o f  death  (n=17; 16%). 
Cause n 
Stroke 7 
Myocardial infarction 7 
Head injury 1 
Hypemephroma 1 
Chronic pancreatitis 1 
series, may be two reasons for these favourable 
results. 
Because only one anastomosis is required, the mean 
operative time of only 89 min in our series is short. 
Sterpetti et al. found SCT (75 min) to be a significantly 
faster procedure than prosthetic CSB (134 min). 7 
Ziomek et al. showed that the use of autologous vein 
(225 min) caused an additional prolongation of the 
CSB procedure when compared with prosthetic SCB 
(159 min). s Increased awareness of health care cost is 
another argument for SCT, which has a short operat- 
ing time and avoids costly synthetic graft material 
with a inherent risk for complications such as early 
graft thrombosis 9'~° and infection. 11 Long term sys- 
temic anticoagulation as required to maintain the 
patency of axillo-axillary bypasses can also be avoided 
with SCT) 2 The complication rate of SCT amounting 
to an overall of 15 % and a permanent morbidity of 
3 % does not differ from other reported series with 
SCT. s'6 In fact the complication rate does not differ 
significantly from the average complication rate of any 
other surgical procedure or PTA. Disregarding syn- 
thetic graft material and operating time, as well as 
complication rates, the major arguments for SCT over 
any other surgical technique are the excellent short 
and long term patency rates, which have not been 
equalled by any other operation or PTA. 
The longitudinal cervical incision used in our 
patients has two advantages in comparison to the 
supraclavicular one used by others. 13 As well as the 
ability to carry out carotid endarterectomy in conjunc- 
tion with SCT, phrenic nerve lesions seem completely 
avoidable. These have been reported in up to 11% 
(4/36) during SCT and up to 15 % (6/41) during CSB 
using the latter approach. 13It is unclear why the left 
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Table 6. Review of the literature. 
Early Late Observation 
Author Year Reconstruction n Complications Mortality reocclusion reocdusion period 
Myers (21) 1979 AX-AX 20 25% 0% 14% 24% mean 26 months 
Criado (22)* 1982 AX-AX 73 10.9% 0% - 8 - 24% 16-36 months 
Weiner (12) 1987 AX-AX 20 25% 0% 10% 0% median 86 months 
Rosenthal (11) 1988 AX-AX 32 6% 0% 0% 13% mean 66 months 
Diethrich (23) 1967 CSB 125 - 4.8% - 6.4% 9 months-14 years 
Eisenhardt (9) 1980 CSB 42 - 0% 7.1% 14.3% mean 76 months 
Criado (22)* 1982 CSB 426 2.5% 1.9% 0.9% 4.4% 3 months-17 years 
Harris (24) 1984 CSB 30 3% 3% 7% 3% 3 months 
Ziomek (8) 1986 CSB 31 6% 3% 10% 25% mean 51 months 
Stock-Denschel (13) 1987 CSB 53 17% 0% - 19.5% mean 55 months 
Farina (10) 1989 CSB 15 13% 0% 13% 0% mean 40 months 
Sterpetti (7) 1989 CSB 18 22% 0% - 14% mean 84 months 
Kretschmer (25) 1991 CSB 19 31% 0% 15% 10% 1-108 months 
Mehigan (26) 1978 SCT 12 0% 0% 0% 0% 48 months 
Criado (22)* 1982 SCT 112 3.5% 0% 0% 0% 6 months-16 years 
Sandmann (5) 1987 SCT 72 2.8% 1.4% 0% 5% mean 45.8 months 
Kretschmer (25) 1991 SCT 32 12% 0% 0% 0% 1-108 months 
Edwards (6) 1994 SCT 178 17% 2.2% 0% 0.5% mean 46 months 
Own 1995 SCT 108 14% 0% 0% 0% mean 70 months 
Ringelstein (16) 1986 PTA 30 30% 0% 13% 54% 6-18 months 
Wilms (17) 1987 PTA 23 13% 0% 8% 13% 6-48 months 
Farina t (10) 1989 PTA 21 14% 0% 8.7% 14% mean 30 months 
Becker ÷ (18) 1989 PTA 423 5% 0.2% 8% 19% 12 months-5 years 
Hebrang (19) 1991 PTA 52 - 0% 13% 21% mean 28 
Bogey ~ (27) 1994 PTA 36 14% 0% 6% ? - -  
*Collected data. 
~Only stenosis. 
AX-AX = axillo-axillary bypass; CSB = carotid subclavian bypass; SCT = subclavian carotid transposition; PTA = percutaneous tansarterial 
angioplasty. 
subclavian artery is so often diseased compared to the 
right. In the literature the ratio of left to right varies 
between 2:121 and 12:1, 26 so that the 9:1 ratio found in 
our patients fits in well with other reported 
series. 12,24,25 
Long term results of PTA are required to prove its 
superiority over SCT. The fear of cerebral emboli 
initially restricted the use of PTA in the treatment of 
supra-aortic vessel disease. However, according to the 
literature, embolic CNS complications are a rare 
event. ~s'16 The reason seems to be a delayed reversal of 
vertebral artery flow, following percutaneous trans- 
luminal angioplasty for subclavian steels  The com- 
plication rate of PTA, however is not significantly 
lower than for SCT, although complications such as 
permanent peripheral nerve lesions are less likely to 
occur. This means that the severity of complications 
may be less pronounced. Nonetheless trokes and 
even fatal complications ~8have been reported. Fur- 
thermore it remains unclear, whether the complication 
rate is elevated when operating on a vessel that has 
been treated with PTA. Our own experience with three 
patients confirms there are technical difficulties due to 
periarterial inflammatory reactions following PTA. 
PTA cannot yet be recommended asthe treatment of 
choice, because it compares poorly to SCT regarding 
patency. An early failure rate between 6 and 13 % and 
a late reocclusion rate of 13-53 % must be expected. 
The overall failure rates of PTA are strongly influ- 
enced by attempts to recannalise occluded vessels, 
which approach 45 % in some series. 19 The failure 
rates for stenoses are much lower. Although a final 
evaluation of the technique is not yet possible today, 
one-argument for PTA is that patients will opt for a 
less invasive procedures if given the choice. 
In conclusion, SCT may be considered the "gold 
standard" in the treatment of proximal subclavian 
artery disease, because it withstands comparison to 
any other treatment on the basis of objective clinical 
data. The most important results are the good overall 
patency rates and that more than 90 % of the patients 
are satisfied and subjectively free from complaints. 
Although it is only suitable for patients with lesions at 
the origin of the vessel this situation occurs in the 
majority of patients, AX-AX, CSB or other bypass 
procedures should be reserved for cases with sympto- 
matic distal subclavian occlusion. In the future, 
prospective randomised studies are required to find 
out whether PTA + stenting can meet he standard of 
SCT. 
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